| 产品描述: | FAAH抑制剂;FAAH Inhibitors;;InformationBIA 10-2474 BIA 10-2474 is a novel fatty acid amide hydrolase (FAAH) inhibitor, with a potent inhibitory effect upon FAAH and prolonged action in vivo. |
| 靶点: |
IC50: 50-70mg/kg (FAAH, rat brain regions) |
| 体内研究: |
In January 2016, severe adverse events (SAE) occurs in the Phase I clinical trial using the drug BIA 10-2474 including one death. The possibilities for failure of trials such as off-target effect, dose calculation, unexpected immune response, species variation, and cumulative dose toxicity would be sought. |
| 参考文献: |
1. Tong J, et al. Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain. J Cereb Blood Flow Metab. 2016 Sep 20. 2. Kaur R, et al. What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. J Pharmacol Pharmacother. 2016 Jul-Sep;7(3):120-6 |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.329 ml |
16.647 ml |
33.293 ml |
| 5 mM |
0.666 ml |
3.329 ml |
6.659 ml |
| 10 mM |
0.333 ml |
1.665 ml |
3.329 ml |
| 50 mM |
0.067 ml |
0.333 ml |
0.666 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |